Hetacin-K Intramammary Infusion

Hetacillin Potassium

For Intramammary Infusion

NADA 55-054, Approved by FDA

Hetacin-K Intramammary Infusion Caution

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Description

HETACIN-K (hetacillin potassium) is a broad-spectrum agent which provides bactericidal activity against a wide range of common gram-positive and gram-negative bacteria. It is derived from 6-aminopenicillanic acid and is chemically related to ampicillin.

Each 10 mL disposable syringe contains hetacillin potassium equivalent to 62.5 mg ampicillin activity in a stable peanut oil gel. This product was manufactured by a non-sterilizing process.

Store at controlled room temperature 15° to 30°C (59° to 86°F).

Action

Hetacillin provides bactericidal levels of the active antibiotic, ampicillin. In vitro studies have demonstrated susceptibility of the following organisms to ampicillin: Streptococcus agalactiae, Streptococcus dysgalactiae, Staphylococcus aureus and Escherichia coli.

Hetacin-K Intramammary Infusion Indications

FOR LACTATING COWS ONLY

For The Treatment Of Acute, Chronic Or Subclinical Bovine Mastitis. Hetacin-k (hetacillin Potassium) For Intramammary Infusion Should Be Used At The First Signs Of Inflammation Or At The First Indication Of Any Alteration In The Milk. Subclinical Infections Should Be Treated Immediately Upon Determining, By C.m.t. Or Other Tests, That The Leucocyte Count Is Elevated, Or That A Susceptible Pathogen Has Been Cultured From The Milk.

hetacin-k For Intramammary Infusion Has Been Shown To Be Efficacious In The Treatment Of Mastitis In Lactating Cows Caused By Susceptible Strains Of streptococcus Agalactiae, Streptococcus Dysgalactiae, Staphylococcus Aureus And escherichia Coli.

polycillin^® (ampicillin) Susceptibility Test Discs, 10 Mcg, Should Be Used To Estimate The in Vitro Susceptibility Of Bacteria To Hetacillin.

dosage And Directions For Use

Infuse the entire contents of one syringe (10 mL) into each infected quarter. Repeat at 24-hour intervals until a maximum of three treatments has been given.

If definite improvement is not noted within 48 hours after treatment, the causal organism should be further investigated.

Wash the udder and teats thoroughly with warm water containing a suitable dairy antiseptic and dry, preferably using individual paper towels. Carefully scrub the teat end and orifice with 70% alcohol, using a separate swab for each teat. Allow to dry.

HETACIN-K (hetacillin potassium) is packaged with the Opti-Sert^® Protective Cap.

For Partial Insertion

For Full Insertion

Insert syringe tip into the teat canal and expel the entire contents of one syringe into each infected quarter. Withdraw the syringe and gently massage the quarter to distribute the medication.

Do not infuse contents of the mastitis syringe into the teat canal if the Opti-Sert Protective Cap is broken or damaged.

Precautions

Because it is a derivative of 6-aminopenicillanic acid, HETACIN-K has the potential for producing allergic reactions. Such reactions are rare; however, should they occur, treatment should be discontinued and the subject treated with antihistamines, pressor amines, such as epinephrine or corticosteroids.

The drug does not resist destruction by penicillinase and, hence, is not effective against strains of staphylococcus resistant to penicillin G.

Warning

Milk that has been taken from animals during treatment and for 72 hours (6 milkings) after the latest treatment must not be used for food.

Treated animals must not be slaughtered for food until 10 days after the latest treatment.

Supply

HETACIN-K (hetacillin potassium) for Intramammary Infusion. Hetacillin potassium equivalent to 62.5 mg of ampicillin activity per syringe.

One 10 mL syringe

Carton containing 12 x 10 mL syringes

NDC 0856-2713-10- 10 mL - syringe

Opti-Sert^® Protective Cap - U.S. Patent No. 4,850,970.

Manufactured for Fort Dodge Animal Health, Fort Dodge, Iowa 50501 USA

by G.C. Hanford Manufacturing Co., Syracuse, NY 13201

00680

Rev. Mar. 2000

4340I

Nac No.